The missing link biomarker in cardiac testing

Welcome to CardiNor
– developing the missing link biomarker test for cardiovascular disease

CardiNor AS is a Norwegian biotech company recently established to handle the commercialization of Secretoneurin (SN), a new biomarker for cardiovascular disease (CVD).

Facts and figures

US cost on cardiovascular disease 3500 USD/sec.
One heart attac in US every 43 sec.

Latest news from CardiNor

CardiNor signs US distribution agreement with IBL-America for the CardiNor Research Use Only Secretoneurin ELISA test. Read more

Contact Us

Send us an email and we'll get back to you, asap.